Hatziagorou, E., Peftoulidou, P., Toulia, I., Tasika, E., Chrysochoou, E., & Tsanakas, J. (2021). EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis. J Cyst Fibros.

Hatziagorou, E., P. Peftoulidou, I. Toulia, E. Tasika, E.-A Chrysochoou, e J. Tsanakas. "EPS1.03 Recommended Shielding against COVID-19 Impacts Physical Activity Levels and Adherence to Airway Clearance Therapy in Patients With Cystic Fibrosis." J Cyst Fibros 2021.

Hatziagorou, E., et al. "EPS1.03 Recommended Shielding against COVID-19 Impacts Physical Activity Levels and Adherence to Airway Clearance Therapy in Patients With Cystic Fibrosis." J Cyst Fibros 2021.